Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Sai Life Sciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Sai Life Sciences IPO: Comprehensive Peer Comparison with Pharmaceuticals Companies
This peer comparison evaluates Sai Life Sciences IPO against key competitors like Divi's Laboratories Limited, Suven Pharmaceuticals Limited and Syngene International Limited. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these Pharmaceuticals companies. This comparison highlights the strengths and positioning of Sai Life Sciences in the competitive landscape of the Pharmaceuticals Industry.
Sai Life Sciences Limited IPO Peer Comparison
| Company Name | EPS | P/E (x) | ROE | ROCE | P/BV | Debt/Equity | RoNW (%) |
|---|---|---|---|---|---|---|---|
| Sai Life Sciences Limited | ₹0.40 | 136.21 | 8.49% | 10.26% | 5.74 | 0.75 | 8.50% |
| Divis Laboratories Limited | ₹69.2 | 88.6 | 12.2% | 16.5% | 11.9 | 0.00 | 12.2% |
| Suven Pharmaceuticals Limited | ₹9.55 | 137 | 14.1% | 18.8% | 16.8 | 0.02 | 14.1% |
| Syngene International Limited | ₹12.0 | 80.3 | 13.2% | 14.7% | 8.42 | 0.14 | 13.2% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
